Clinical Trial

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a 2-arm, noncomparative phase 2 trial designed to evaluate treatment outcomes with or without the addition of ciprofloxacin, metronidazole, and aspirin to first-line chemotherapy for patients with stage IV colorectal cancer (CRC).
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-12-05; most recent amendment 2026-05-05.
Status change: Not Yet Recruiting → Recruiting 2025-03-12
Trial Details
NCT Number NCT06728072
Lead Sponsor Virginia Commonwealth University
Collaborators: American Cancer Society, Inc.
Conditions Colorectal Cancer, CRC
Enrollment 97 participants
Start Date 2025-03-07
Primary Completion 2035-07-01 (estimated)
Study Completion 2035-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-06